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Phenol is not reliable as a biomarker for exposure to benzene at concentrations below 5 ppm
(8-hr time-weighted average [TWAI). S-Phenylmercapturic acid (S-PMA) and trans-trans-muconic
acid (tt-MA), two minor urinary metabolites of benzene, have been proposed as biomarkers for
low-level exposures. The aim of this study was to compare their suitability as biomarkers. S-PMA
and tt-MA were determined in 434 urine samples collected from 188 workers in various settings
in the petrochemical industry and from 52 control workers with no occupational exposure to
benzene. Benzene concentrations in the breathing zone of the potentially exposed workers were
assessed by personal air monitoring. Strong correlations were found between S-PMA and tt-MA
concentrations in end-of-shift samples and between either of these parameters and airborne
benzene concentrations. Exposure to 1 ppm benzene (8-hr TWA) leads to an average
concentration in end-of-shift samples of 21 mol S-PMA and 1.5 mmol tt-MA per mol creatinine.
Of an inhaled dose of benzene, on average 0.1 1 % (range 0.05-0.26%) was excreted as S-PMA
with an apparent elimination half-life of 9.1 (standard error [SE] 0.7) hr and 3.9% (range 1.9-7.3%)
as tt-MA with a half-life of 5.0 (SE 0.5) hr. Due to its longer elimination half-life, S-PMA proved a
more reliable biomarker than tt-MA for benzene exposures during 12-hr shifts. Specificity of
S-PMA, but not tt-MA, was sufficient to discriminate between the 14 moderate smokers and the
38 nonsmokers from the control group. The mean urinary S-PMA was 1.71 (SE 0.27) in smokers
and 0.94 (SE 0.15) mol/mol creatinine in nonsmokers (p=0.013). The mean urinary tt-MA was
0.046 (SE 0.010) in smokers and 0.029 (SE 0.013) mmol/mol creatinine in nonsmokers (p=0.436).
The inferior specificity of tt-MA was due to relatively high background values of up to 0.56
mmol/mol creatinine, which may be found in nonexposed individuals and limits the use of tt-MA
to concentrations of benzene over 1 ppm (8-hr TWA). We conclude that S-PMA is superior to
tt-MA as a biomarker for low-level benzene exposures because it is more specific, enabling
reliable determination of benzene exposures down to 0.3 ppm (8-hr TWA), and because its longer
half-life makes it more suited for biological monitoring of operators working in shifts longer than
8 hr. Environ Health Perspect 104(Suppl 6):1151-1157 (1996)
Keywords: benzene, biological monitoring, biomarkers, S-phenylmercapturic acid, trans-trans-
muconic acid
Introduction
Long-term occupational exposure to high
concentrations ofbenzene (100-500 ppm)
has been associated with potential adverse
health effects, including leukemogenesis (1).
Therefore, exposure to benzene should be
minimized. From the late 1980s on, propos-
als were made and adopted in many coun-
tries to lower the occupational exposure
limit value for benzene from 10 to 1 ppm
(8-hr time-weighted average [TWA]). In
some countries, even lower values have
been adopted (e.g., 0.5 ppm in Sweden) or
proposed (0.3 ppm in the United States)
(2,3). Urinary phenol is not suitable as a
biomarker for benzene exposure at levels
below approximately 5 ppm due to its high
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and variable background caused by
endogenous production of phenol as well
as dietary and environmental exposure to
phenol. Thus, new biological monitoring
techniques were needed to evaluate the
effectiveness of control measures. Two
minor urinary metabolites of benzene,
trans-trans-muconic acid ([tt-MA], 2,4-
hexadienedioic acid) (Figure 1) and S-
phenylmercapturic acid ([S-PMA],
N-acetyl-S-phenyl-L-cysteine) (Figure 1),
were proposed to replace phenol in biologi-
cal monitoring of exposure to benzene
(4,5). Since only S-PMA seemed to enable
detection ofexposure to benzene at levels
below 1 ppm, the method ofStommel and
co-workers (5) for determination of uri-
nary S-PMA was modified in our labora-
tory to be applicable for routine biological
monitoring. This S-PMA test was validated
in 12 separate studies in various chemical
manufacturing plants, oil refineries, and
natural gas production installations and
proved a reliable and sensitive biomarker
capable of measuring 8-hr TWA benzene
exposures of 0.3 ppm and higher (6). In
the past few years, the method by Inoue
and coworkers for assessment oftt-MA has
also been modified by several investigators,
and a sensitivity as low as 1 ppm (8-hr
TWA) has been reported (7-9). The deter-
mination of S-PMA requires gas chro-
matography-mass spectrometry (GC-MS),
whereas the determination of tt-MA is
based on high performance liquid chro-
matography (HPLC) analysis, which is in
general more readily available in a labora-
tory and easier to operate. We measured
tt-MA and S-PMA in workers with poten-
tial occupational exposure to benzene and
control workers to compare the suitability




S-Phenylmercapturic acid (> 98%), tt-MA
(> 98%), and acetic acid (> 99.7%) were
purchased from Janssen Chimica (Goirle,
the Netherlands). Ethyl acetate (> 99.5%,
HPLC grade), dichloromethane (coffee
grade), methanol (> 99.9%, capillary GC
grade) and purified water (HPLC grade)
were obtained from J.T. Baker Chemicals
(Deventer, the Netherlands). Hydrochloric
acid gas (technical grade) was purchased from
Hoekloos (Schiedam, the Netherlands).
S-[Pentadeuterophenyl]mercapturic acid





















Figure 1. Some metabolic pathways of benzene and urinary excretion of benzene metabolites. Indicated are the
formation of tt-MA, phenol, and S-PMA and the percentage of the retained dose excreted into the urine after
inhalation of benzene vapors for each ofthese metabolites.
(d5-S-PMA) was synthesized from d5-aniline
as described previously (10).
StudyPopulations andCollections
ofUrinaryandAirborneSamples
Urinary tt-MA and S-PMA were determined
in 52 employees without potential exposure
to benzene for the estimation of normal
values. This control group comprised 14
smokers and 38 nonsmokers.
For the comparison of the biomarkers,
434 urine samples were collected between
1992 and 1994 from 188 workers with
potential exposure to benzene during
manufacturing and maintenance operations
in three off-shore natural-gas production
installations, in two refineries with aromat-
ics plants, in various chemical plants, and
during loading ofroad tankers with gaso-
line. The numbers ofsamples collected, the
number ofworkers involved, and the dura-
tion oftheshifts are summarized in Table 1.
Urine samples were collected in poly-
ethylene bottles and acidified to pH 2 by
addition of6 M hydrochloric acid. Stability
studies ofS-PMA and tt-MA in urine had
shown that concentrations did not change
under these conditions for at least a month
ifstored at room temperature or 40C (10).
The samples were transported to the Shell
Biomedical Laboratory, Rotterdam, for
determination of urinary S-PMA, tt-MA
and creatinine. Urinary creatinine was pre-
viously shown to provide a good adjustment
for the variations in concentration of spot
urine samples due to differences in fluid
intake among workers (6,10). For many
workers with potential exposure to benzene,
personal air sampling of benzene in the
breathing zone was performed by local staff
using 3M gas diffusion badges or charcoal
tubes. The absorbed benzene vapors were
desorbed by carbon disulfide and the solu-
tion was analyzed using a gas chromato-
graphic method with flame ionization
detection. Sampling and analysis were
according to standard methods published by
the National Institute for Occupational
Safety and Health (11). No personal air
monitoring data were available from the
workers involved in the loading of road
tankers, the operators in one of the oil
refineries, or theworkers in one ofthe chem-
ical plants. From some ofthe workers in the
other chemical plants, no personal air moni-
toring data were available because biological
monitoring was applied after accidental
potential exposure to benzene (Table 1).
Determination ofUrinaryMetabolites
For the determination of tt-MA, the
method by Ducos et al. (7,8) was modified
because the recovery oftt-MA appeared to
be dependent on the urinary pH with some
brands ofthe quaternary ammonium ion
exchange resin (SAX columns) used.
Alkalization ofthe samples to pH 7 to 10
prior to extraction gave optimum recover-
ies, which were invariably over 95% (10).
An aliquot of 1.00 ml ofalkaline urine was
applied to a SAX column, which was sub-
sequently washed with 3 ml 1% (v/v) aque-
ous acetic acid. The tt-MA was then eluted
Table 1. Summary of benzene exposure monitoring studies in various petrochemical industries.
Urinary metabolites Airborne benzene
tt-MA, S-PMA, No. ofworkers, No. ofworkers,
mmol/mol creatinine pmol/mol creatinine measurements Concentration, measurements
Operation Start of shift End of shift Start of shift End of shift 8-hr shift 12-hr shift mg/m3, 8-hrTWA 8-hr shift 12-hr shift
Natural gas
production platforms < 0.01-2.6 < 0.01-9.92 < 0.5-235 <0.5-378 - 24(70) <0.1-19.2 - 24(59)
Chemical
manufacturing <0.01-0.06 < 0.01-31.3 0.9-21.8 < 1-1096 130(226) 4(22) <0.01-100 50(102) 4(22)
Oil refineries with
aromatics plants - 0.008-1.20 - 0.9-46.4 16(22) - 0.11-3.30 8(14) -
Road tanker
loading 0.008-0.33 0.009-0.83 <0.5-6.64 0.5-8.0 14(42) - - - -
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with 4 ml 10% (v/v) aqueous acetic acid
into calibrated tubes and the volume made
up to 5.0 ml with purified water. Aliquots
(20 pl) of this solution were analyzed by
HPLC with UV (X=259 nm) detection
(Hewlett Packard 1084B) at 20°C using a
100 x 2.1 mm stainless steel column with
Spherisorb 5 ODS-2 as immobile phase
and 20% (v/v) methanol in 1% (v/v) aque-
ous acetic acid as mobile phase (flow rate 1
ml/min). For calibration, a series oftt-MA
standards prepared in fresh control urine
samples were analyzed together with the
urine samples. A more effective clean-up
was an adventitious effect of the alkaliza-
tion ofthe samples that lowered the detec-
tion limit to 70 nM. The coefficient of
variation of replicate analyses (n= 10) was
3.2 and 0.4% at spiked concentrations of
4.51 and 39.1 pM, respectively. The repro-
ducibility was tested by analysis of a set of
identical samples in a series (n=6) ofruns.
The coefficient of variation was 11 and
2.7% for samples with a spiked concentra-
tion of 7.82 and 39.2 pM, respectively.
With this procedure, up to 40 urine
samples could be analyzed in 1 day.
For the determination of S-PMA,
d5-S-PMA was added to an aliquot ofthe
acidified urine sample, which was subse-
quently extracted with ethyl acetate. After
evaporation ofthe solvent, the residue was
methylated using a solution of 1.0 M hydro-
chloric acid in methanol. The organic phase
was evaporated and the residue dissolved in
dichloromethane and analyzed by GC-MA
as described previously (6,10). The use of
d5-S-PMA as internal standard allowed a
limit of detection of 4 nM. A series of
urine samples was pooled, spiked with
S-PMA at two different concentrations,
acidified, and stored frozen at -20°C. In all
runs, a set ofsamples from this urine pool
was analyzed to check the reproducibility of
the method. The coefficients ofvariation
between different runs (n=42) were 8.9 and
6.1% for the pools with 118 and 437 nM
S-PMA, respectively. The coefficients of
variation ofreplicate analyses (n= 10) were
2.5 and 3.5% at spiked concentrations of55
and 211 nM S-PMA, respectively. With this
procedure, up to 30 urine samples could be
analyzed in one day.
Creatinine was determined as described
previously (6).
Caculations andStatistics
The cumulative excretions of tt-MA and
S-PMA were estimated from the area under
the curve (AUC) from urinary excretion vs
time plots and were used to estimate the
percentages ofthe respiratory benzene dose
excreted as tt-MA and S-PMA into the
urine. AUCs were calculated using the lin-
ear trapezoidal rule in the absorption
phases and the logarithmic trapezoidal rule
in the elimination phases as described pre-
viously (6,10). Apparent urinary elimina-
tion rate constants (ke) for S-PMA and
tt-MA were calculated from workers who
had provided urine samples at the begin-
ning and end ofa shift on at least two con-
secutive days. For the calculation of each
ke, it was assumed that the absorption was
completed and that first-order elimination
kinetics were obeyed during the collection
period. In some cases, the absorption phase
was not yet completed at the end of the
shift. In these cases, ke was calculated from
the decline in metabolite during the same
shift but only if there was no detectable
exposure to benzene. For most workers,
values for ke could be calculated more than
once. In these cases the separate values
were averaged. From the averaged values,
the corresponding half-life (t1/ ) was calcu-
lated for each worker using the following
formula: t1/2 = - ln(2)/ke (6,10).
For all statistical calculations, the main-
frame version ofthe SAS software package,
version 6.07 (SAS Institute, Cary, NC),
was used. For S-PMA and tt-MA results
below the calculated value for the limit of
detection ofthe respective methods, halfof




The tt-MA concentrations were plotted
against the S-PMA concentration in the
same urinary sample, both following loga-
rithmic transformation, for all 188 workers
in the study (Figure 2). For many workers,
more than one set of values was deter-
mined. In these cases the set ofvalues corre-
sponding to the highest airborne benzene
concentration, or the set with the highest
value of S-PMA if no air measurements
were performed, was chosen. A statistically
highly significant correlation (r= 0.79,
p<0.0001) between tt-MA and S-PMA was
found. This correlation is described by the
following equation: log (tt-MA [mmol/mol
creatinine]) = 0.824 (SE 0.048) x log (S-
PMA [mol/mol creatinine]) - 0.993 (SE
0.062). Nevertheless, some deviations were
observed. In some cases where no exposure
to benzene had occurred, relatively high
concentrations of tt-MA (up to 0.56
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Figure 2. Relationship between urinary concentrations
of tt-MA and S-PMA in 188 workers exposed to ben-
zene. The solid line represents the regression line, and
the broken lines represent the 95% tolerance limits of
the confidence interval for individual (outer lines) and
group (inner lines) results.
urine (with no concomitant S-PMA,
concentration < 0.5 mol/mol creatinine).
UrinaryExcretion Kinetics
oftt-MAandS-PMA
Typical urinary excretion vs time plots from
two workers who were biologically moni-
tored for 3 consecutive days are shown in
Figure 3. The first worker (Figure 3A)
worked 8-hr shifts and was exposed to very
low concentrations ofbenzene (0.6 mg/mi3,
8-hr TWA) during the first 2 working days
and to slightly higher concentrations on
the third working day (2.4 mg/m3, 8-hr
TWA). The second worker (Figure 3B)
worked 12-hr shifts and was exposed to
higher concentrations of benzene: 1.95,
5.20, and 3.25 mg/m3 (8-hr TWA) on the
first, second, and third day, respectively. As
shown in both graphs, excretion oftt-MA
and S-PMA obviously followed the same
pattern, and the excretion ofboth metabo-
lites reflected the exposure to benzene.
These graphs also indicate that the urinary
excretion half-life was longer for S-PMA
than for tt-MA and that tt-MA returned
to baseline values at the beginning of the
next shift after exposure to benzene below
approximately 1 ppm, whereas S-PMA
tended to accumulate.
For 27 workers who provided pre- and
post-shift urine samples on at least 2 consec-
utive days, values for the apparent urinary
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Figure 3. Urinary excretion of S-PMA lo) and tt-MA
(() in two operators working in 8-hr shifts (A) and
12-hr shifts (B) during 3 consecutive days.
excretion constants could be calculated from
38 and 52 data points for S-PMA and
tt-MA, respectively. The median ke was
0.077 liters/hr for S-PMA and 0.136
liters/hr for tt-MA. These values correspond
to apparent elimination half-lives of9.1 (SE
0.7) and 5.0 (SE 0.5) hr, respectively. For
14 workers, sufficient personal air monitor-
ing and biological monitoring data were col-
lected to allow estimations of the urinary
excretions oftt-MA and S-PMA as percent-
ages of the dose of inhaled benzene. The
average percentage ofthe dose that excreted
as tt-MA was 3.9% (range 1.9-7.3%) and





The relationship between airborne benzene
exposures (8-hr TWA) and urinary S-PMA
and tt-MA concentrations in samples col-
lected at the end of the shift from the 58
workers on 8-hr shift duty are shown in
9' ,
0Z~~~~~~ /
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Figure 4. Relationship between respiratory 8-hr TWA exposure to benzene and concentrations of S-PMA and
tt-MA in urinary samples collected at the end of an 8-hr shift from 58 operators working in chemical manufacturing
plants and oil refineries with aromatics plants. The solid lines represent the regression lines, and the broken lines
represent the 95% tolerance limits of the confidence interval for individual (outer lines) and group (inner lines)
results. The regression line for S-PMA is given by log (benzene [mg/m3, 8-hr TWA]) = 0.782 (SE 0.064) x log (S-PMA
[pmol/mol creatinine]) - 0.518 (SE 0.081); r= 0.885. The regression line for tt-MA is given by log (benzene [mg/m3,
8-hr TWA]) = 1.04 (SE 0.072) x log (tt-MA [mmol/mol creatinine]) + 0.320 (SE 0.040); r= 0.888.
Figure 4. The actual working hours for
these operators were close to 8 hr. Data
from workers who had worn respiratory
protection during the monitoring period
were excluded from the statistics. In cases
in which more than one data point had
been generated for a worker, the data point
with the highest airborne benzene level was
used for the linear regression analysis after
logarithmic transformation of the airborne
benzene concentration data and the uri-
nary metabolite data. Highly significant
correlations (p<0.0001) were found for
both S-PMA and tt-MA.
From the regression lines, it was
calculated that the average concentration in
a urine sample collected at the end of the
shift following an 8-hr TWA benzene
exposure to 1 ppm (3.25 mg/m3), would
be 21 pmol S-PMA/mol creatinine and 1.5
mmol tt-MA/mol creatinine. The corre-
sponding 95% tolerance limits of the
confidence interval for the group means
were 17 to 27 pmol S-PMA/mol creatinine
and 1.3 to 1.8 mmol tt-MA/mol creati-
nine, respectively.
A separate regression analysis was made
using the data collected from the 28 opera-
tors working 12-hr shifts (Figure 5). Again,
only one set ofdata was included for each
worker, and data collected while respiratory




The 38 nonsmokers in the control group
had a mean urinary tt-MA concentration
of0.029 (SE 0.013), while the 14 smokers
had a concentration of 0.046 (SE 0.013)
mmol/mol creatinine. The mean S-PMA
concentration in the 38 nonsmokers was
0.94 (SE 0.15) and in the 14 smokers 1.71
(SE 0.27) pmol/mol creatinine. The differ-
ence in tt-MA between smokers and non-
smokers was not statistically different
(p = 0.436), but the difference in S-PMA
was (p=0.013, two-tailed Student's t-test
for unpaired data). S-PMA was present at
detectable concentrations in the urine ofall
14 smokers and in urine samples of 20 of
the 38 nonsmokers. Urinary concentra-
tions of tt-MA in 3 smokers and 29 non-
smokers were below the detection limit.
Discussion
Lowering the occupational limit values for
benzene has made urinary phenol obsolete
as a biomarker for benzene exposure. Two
minor metabolites of benzene (Figure 1)
have been proposed to replace phenol as a
biomarker for benzene exposure: S-PMA
(5,6) and tt-MA (4,7). The suitability of
these new biomarkers in terms of speci-
ficity, sensitivity, and ease ofoperation was
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Figure 5. Relationship between respiratory 12-hr TWA exposure to benzene and concentrations of S-PMA and
tt-MA in urinary samples collected at the end of a 12-hr shift from 28 operators working in off-shore natural gas
production platforms and in chemical manufacturing. The solid lines represent the regression lines and the broken
lines represent the 95% tolerance limits of the confidence interval for individual (outer lines) and group (inner
lines) results. The regression line for S-PMA is given by log (benzene [mg/m3, 12-hr TWA)) 1.243 (SE 0.094) x log
(S-PMA [pmol/mol creatininel) - 1.24 (SE 0.11); r= 0.937. The regression line for tt-MA is given by log (benzene
[mg/m3, 12-hr TWA]) = 0.92 (SE 0.13) x log (tt-MA [mmol/mol creatininel) + 0.33 (SE0.14); r= 0.819.
investigated by analyzing 434 urine sam-
ples collected from 188 workers with
potential exposure to benzene and 52
control workers.
The method for determining S-PMA in
urine using S-benzylmercapturic acid as an
internal standard was validated in a series of
studies in workers in petrochemical indus-
tries (6). The use ofd5-S-PMA as an inter-
nal standard in the present study decreased
interference ofmatrix effects, which resulted
in a 4 nM limit of detection. Another
advantage ofd5-S-PMA over S-benzylmer-
capturic acid is that the latter may also be
found in trace amounts in the urine ofwork-
ers exposed to toluene (10,12). Overall, the
present studies confirmed the previous
observations that S-PMA is a reliable bio-
marker for exposure to concentrations of
benzene well below 1 ppm (8-hr TWA).
The method for determining tt-MA as
described by Ducos and co-workers (7,8)
gave irreproducible results with some
brands of quaternary ammonium exchange
columns because the recovery of tt-MA
from these columns appeared dependent
on the pH ofthe urine samples. This prob-
lem could be solved by adjusting the pH of
the samples to a pH of 7 to 10 with
sodium hydroxide prior to extraction. The
solid-phase extraction was apparently more
efficient at higher pH, which resulted in
cleaner extracts and a lower limit ofdetec-
tion (70 nM). Overall, the method proved
simple, straightforward, and robust, which
resulted in small intrarun as well as interrun
variation coefficients.
In our previous studies we did not find
a statistically significant difference in uri-
nary S-PMA in smokers compared with that
in nonsmokers (6). Due to the increased
sensitivity of the S-PMA determination,
benzene uptake from cigarette smoking was
now detectable in all 14 smokers from the
control group. In 20 ofthe 38 nonsmokers
of the control group S-PMA could also be
detected, albeit in much lower concentra-
tions. The difference in urinary S-PMA of
the 14 smokers (1.71 pmol/mol creatinine,
SE 0.27) and the 38 nonsmokers (0.94
pmol/mol creatinine, SE 0.15) from the
control group was statistically significant.
In some smokers and most nonsmokers the
concentrations of tt-MA were below the
detection limit and there was no statisti-
cally significant difference in urinary tt-MA
in the smokers (0.046 mmol/mol creati-
nine, SE 0.010) and nonsmokers (0.029
mmol/mol creatinine, SE 0.013). This is in
apparent contrast to two recent studies in
which significant differences were observed
between mean urinary tt-MA concentra-
tions in 35 smokers and 23 nonsmokers
(0.15 vs 0.11 mmol/mol creatinine) (9)
and between 42 smokers and 42 nonsmok-
ers (0.23 vs 0.07 mmol/mol creatinine)
(13). From the absolute values, however, it
may be concluded that the smokers in these
two studies consumed much larger quanti-
ties ofcigarettes than the moderate smokers
in our control group. This, of course,
makes the difference found in S-PMA more
prominent. The mean background values
in the nonsmokers in these studies are high
compared to our results. The investigators
contributed these backgrounds to environ-
mental pollution. However, they might be
due to matrix interference. In a recent study
that used a GC-MS method for the deter-
mination oftt-MA to avoid interference by
other compounds from the urinary matrix
with tt-MA, the background was only
0.043 mmol/mol creatinine (SE 0.04) in
nonsmokers versus 0.071 mmol tt-MA/mol
creatinine (SE 0.09) in smokers (14).
Relatively high background values of
tt-MA in individuals without exposure to
benzene have repeatedly been reported
(8,13,15,16). This background is partly
due to compounds in the urine that
coelute with tt-MA in the HPLC analysis.
Bartczak and co-workers (17) showed that
modifying the HPLC-based assay of
tt-MA, as described by Ducos et al. (8), by
using a diode array detector increased the
specificity by identifying false positives.
However, the diode array detector is less
sensitive (limit of detection 0.6 pM) and,
moreover, GC analysis showed that in
some samples peaks were falsely identified
as tt-MA even with the diode array detector,
and in other samples the concentration of
tt-MA was overestimated (17). Recently, a
GC-MS-based assay for the determination
of tt-MA with a similar detection limit as
our HPLC method (70 nM) was reported
(14). Although this method is highly spe-
cific for tt-MA, some tt-MA could still be
detected in nonsmoking individuals who
were not occupationally exposed to ben-
zene (14). These traces of tt-MA may be
due to consumption of sorbic acid, which
is used as a preservative in many foodstuffs
and is metabolized to tt-MA (7,14,18).
Based on spot samples collected from 27
workers on two or more consecutive days,
the average apparent urinary elimination
half-life (t1/2) for S-PMA was estimated at
9.1 hr (SE 0.7), which is very similar to the
t1/2 of 9.0 hr (SE 0.8) previously reported
(6). For tt-MA, the estimated tl/2 for tt-MA
was 5.0 hr (SE 0.5), which is in line with
the observation that tt-MA and phenol have
similar half-lives (7). The average percentage
ofthe doses of inhaled benzene that were
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excreted in the urine as S-PMA was 3.9%
(range 1.9-7.3%), which is very similar to
our previous findings (6). For tt-MA a
value of 0.1 % (range 0.05-0.26%) was
found, which is about twice the only value
reported thus far (1.9%) (4). This differ-
ence is partlyexplained by the lower respira-
tion rate of 0.9 liters/hr used for the
estimation by Inoue and co-workers com-
pared with the rate we used (1.25 liters/hr).
The rather wide ranges for urinary excretion
as a percentage ofthe dose for both tt-MA
and S-PMA excretion may be due partly to
the fact that the calculations are based on
spot samples, which carries the inherent risk
ofunder- and overestimation ofAUC.
A good correlation between tt-MA and
S-PMA (Figure 2) was found, and the values
for S-PMA and tt-MA that were recently
determined in 26 car mechanics (19) fit this
correlation well. Also good correlations were
found between either S-PMA or tt-MA and
airborne benzene concentrations (Figures 4,
5). The confidence intervals in Figure 4 as
well as the correlation coefficients for the
regression lines indicate that the reliability
of tt-MA and S-PMA as biomarkers for
benzene exposure during 8-hr shifts is
approximately identical. Figure 5 shows that
the reliability oftt-MA as a biomarker for
benzene exposure during 12-hr shifts is
much less than for S-PMA, which is fully
due to its shorter elimination half-life.
From the correlation found between both
S-PMA and tt-MA with the airborne con-
centration ofbenzene, it follows that expo-
sure to 1 ppm benzene (8-hr TWA) will
lead to an average excretion of21 pmol S-
PMA and 1.5 mmol tt-MA/mol creatinine
in urine samples collected at the end ofthe
shift. These values seem to be confirmed by
the regression equation in Figure 2, from
which it can be calculated that 21 pmol S-
PMA/mol creatinine corresponds to 1.3
mmol tt-MA/mol creatinine. This value for
tt-MA is slightly less than the value of 1.5
mmol/mol creatinine. This is explained by
the fact that values from workers on 12-hr
shift duty, which in general will be lower
because the half-life of tt-MA is much
shorter than the half life of S-PMA, are
also included in the correlation between
tt-MA and S-PMA. The value of 21
pmol/mol creatinine for S-PMA also agrees
well with the findings from our previous
studies, where a value of22 mol/mol crea-
tinine was found (6), which is now
accepted as the exposure equivalent for car-
cinogenic substances (EKA) at 1 ppm (8-hr
TWA) (20). The value of 1.5 mmol/mol
creatinine for tt-MA is higher than the val-
ues of0.07 mM and 1.1 mmol/mol creati-
nine that were found corresponding with
exposure to 1 ppm benzene (8-hr TWA) in
two other studies but well in line with the
EKA for tt-MA at 1 ppm benzene (8-hr
TWA) of 0.014 mM (20), which corre-
sponds to 1.6 mmol/mol creatinine,
assuming an average urinary creatinine
concentration of 1 g/liter.
In the present study the suitability of
tt-MA and S-PMA as biomarkers for
exposure to low concentrations ofbenzene
was compared. Although the analytical sen-
sitivity ofthe S-PMA assay is much higher
(detection limit of4 nM) than that of tt-
MA (detection limit of 70 nM), tt-MA
potentially is a more sensitive biomarker
than S-PMA because 3.9% on average will
be excreted as tt-MA and only 0.11% as S-
PMA following inhalation exposure to low
concentrations ofbenzene. Another reason
to prefer the HPLC-based tt-MA assay
over the GC-MS-based S-PMA assay
might be that the tt-MA assay is easier to
perform and enables a larger sample
throughput than GC-MS and also that
HPLC is more readily available than
GC-MS in many cases. Due to the rather
expensive solid-phase extraction, the analy-
sis of tt-MA approximately equals the
analysis of S-PMA in terms of costs per
sample. An important drawback, however,
ofthe HPLC-based tt-MA assay is its lack
of specificity, which precludes reliable
detection of benzene exposure below
approximately 1 ppm (8-hr TWA), whereas
S-PMA allows detection ofconcentrations
as low as 0.3 ppm (8-hr TWA). This disad-
vantage of the HPLC-based tt-MA assay
may to a great extent be overcome by using
a diode array detector, but this will result
in a major loss ofsensitivity (17). Another
option is to apply GC-MS for determina-
tion oftt-MA. However, the methods now
developed are more cumbersome and
time-consuming than the GC-MS-based
S-PMA assay (14,17). Also, the specificity
problem caused by the conversion of
dietary sorbic acid to tt-MA will remain.
Since the longer urinary half-life ofS-PMA
compared with that of tt-MA also makes
S-PMA a more reliable biomarker for
workers in shifts longer than 8 hr, we con-
clude that S-PMA is superior to tt-MA as a
biomarker for exposure to low concentra-
tions ofbenzene.
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